Testosterone and the Cardiovascular System: A Comprehensive Review of the Clinical Literature

Recent data from the Massachusetts Male Aging Study (MMAS) have revealed an increasing incidence of hypogonadism within the aging US population. The Massachusetts Male Aging Study estimates indicate that ≈2.4 million men aged 40 to 69 suffer from hypogonadism in the United States.[1][1] The

[1]  C. Hayward,et al.  Effects of testosterone on coronary vasomotor regulation in men with coronary heart disease. , 1999, Circulation.

[2]  E. Barrett-Connor,et al.  Endogenous sex hormones and cardiovascular disease in men. A prospective population-based study. , 1988, Circulation.

[3]  L. Niskanen,et al.  Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. , 2004, Diabetes care.

[4]  H. Völzke,et al.  The association of serum testosterone levels and ventricular repolarization , 2009, European Journal of Epidemiology.

[5]  M. Szklo,et al.  Association of endogenous sex hormones with diabetes and impaired fasting glucose in men: multi-ethnic study of atherosclerosis. , 2009, Diabetes care.

[6]  A. Araujo,et al.  Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging Study. , 2004, The Journal of clinical endocrinology and metabolism.

[7]  K. Channer,et al.  The effect of testosterone on insulin sensitivity in men with heart failure , 2007, European journal of heart failure.

[8]  H. Völzke,et al.  Low serum testosterone levels are associated with increased risk of mortality in a population-based cohort of men aged 20-79. , 2010, European heart journal.

[9]  M. Dowsett,et al.  Endogenous Testosterone and Mortality Due to All Causes, Cardiovascular Disease, and Cancer in Men: European Prospective Investigation Into Cancer in Norfolk (EPIC-Norfolk) Prospective Population Study , 2007, Circulation.

[10]  D. Grobbee,et al.  Oral testosterone supplementation and chronic low-grade inflammation in elderly men: a 26-week randomized, placebo-controlled trial. , 2007, American heart journal.

[11]  J. Murabito,et al.  Endogenous Sex Hormones and Cardiovascular Disease Incidence in Men , 2006, Annals of Internal Medicine.

[12]  A. Araujo,et al.  Endogenous Testosterone and Mortality in Men: A Systematic Review and Meta-Analysis , 2011 .

[13]  N. Bayley,et al.  Failure , 1890, The Hospital.

[14]  David Handelsman,et al.  Prospective Study of Effect of Androgens on Serum Inflammatory Markers in Men , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[15]  I. Njølstad,et al.  Endogenous sex hormones and the prospective association with cardiovascular disease and mortality in men: the Tromsø Study. , 2009, European journal of endocrinology.

[16]  A. Lenzi,et al.  Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle‐aged men: a meta‐analysis , 2005, Clinical endocrinology.

[17]  G. B. Phillips,et al.  The association of hypotestosteronemia with coronary artery disease in men. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[18]  V. Montori,et al.  Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. , 2006, The Journal of clinical endocrinology and metabolism.

[19]  K. Cao,et al.  Testosterone is negatively associated with the severity of coronary atherosclerosis in men. , 2012, Asian journal of andrology.

[20]  J. Salonen,et al.  Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[21]  G. Rosano,et al.  Acute anti-ischemic effect of testosterone in men with coronary artery disease. , 1999, Circulation.

[22]  Hong Jiang,et al.  Low testosterone level in middle-aged male patients with coronary artery disease. , 2011, European journal of internal medicine.

[23]  D. Grobbee,et al.  Association of endogenous sex hormone with C‐reactive protein levels in middle‐aged and elderly men , 2007, Clinical endocrinology.

[24]  T. Furukawa,et al.  Nontranscriptional Regulation of Cardiac Repolarization Currents by Testosterone , 2005, Circulation.

[25]  A. Araujo,et al.  Sex steroids and all-cause and cause-specific mortality in men. , 2007, Archives of internal medicine.

[26]  D. Mellström,et al.  Low serum testosterone and estradiol predict mortality in elderly men. , 2009, The Journal of clinical endocrinology and metabolism.

[27]  R H Selzer,et al.  The Role of Carotid Arterial Intima-Media Thickness in Predicting Clinical Coronary Events , 1998, Annals of Internal Medicine.

[28]  Eary,et al.  CAROTID-ARTERY INTIMA AND MEDIA THICKNESS AS A RISK FACTOR FOR MYOCARDIAL INFARCTION AND STROKE IN OLDER ADULTS , 2000 .

[29]  R. Huupponen,et al.  Serum testosterone but not leptin predicts mortality in elderly men. , 2008, Age and ageing.

[30]  R. Kronmal,et al.  Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. , 1999, The New England journal of medicine.

[31]  O. Joakimsen,et al.  Low testosterone levels are associated with carotid atherosclerosis in men , 2006, Journal of internal medicine.

[32]  O. Raitakari,et al.  Increased carotid atherosclerosis in andropausal middle-aged men. , 2005, Journal of the American College of Cardiology.

[33]  Hiroshi Morita,et al.  The QT syndromes: long and short , 2008, The Lancet.

[34]  J. Ladny,et al.  An assessment of correlations between endogenous sex hormone levels and the extensiveness of coronary heart disease and the ejection fraction of the left ventricle in males. , 2003, The journal of medical investigation : JMI.

[35]  E. Cairrão,et al.  PKG is involved in testosterone-induced vasorelaxation of human umbilical artery. , 2010, European journal of pharmacology.

[36]  C. Glueck,et al.  Testosterone Therapy, Thrombophilia–Hypofibrinolysis, and Hospitalization for Deep Venous Thrombosis-Pulmonary Embolus , 2014, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[37]  S. Haffner,et al.  Relationship of sex hormones to lipids and lipoproteins in nondiabetic men. , 1993, The Journal of clinical endocrinology and metabolism.

[38]  İ. Can,et al.  Men with coronary artery disease have lower levels of androgens than men with normal coronary angiograms. , 2001, European heart journal.

[39]  P. Rizzon,et al.  Free testosterone plasma levels are negatively associated with the intima-media thickness of the common carotid artery in overweight and obese glucose-tolerant young adult men , 2003, International Journal of Obesity.

[40]  J. Hansen,et al.  Low serum testosterone in men is inversely associated with non-fasting serum triglycerides: the Tromsø study. , 2008, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[41]  D. Mayes,et al.  Age differences in serum androgen levels in normal adult males. , 1981, Human biology.

[42]  H. Okut,et al.  The effects of short term (3 weeks) testosterone treatment on serum inflammatory markers in men undergoing coronary artery stenting. , 2006, International journal of cardiology.

[43]  C. Peers,et al.  Testosterone is a potent inhibitor of L-type Ca(2+) channels. , 2004, Biochemical and biophysical research communications.

[44]  J. Orav,et al.  Reproductive axis suppression in acute illness is related to disease severity. , 1993, The Journal of clinical endocrinology and metabolism.

[45]  P. Ridker,et al.  Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. , 1997, The New England journal of medicine.

[46]  Rüdiger Klein,et al.  Role of Brain Insulin Receptor in Control of Body Weight and Reproduction , 2000 .

[47]  K. Hashiba.  Sex Differences in Phenotypic Manifestation and Gene Transmission in the Romano‐Ward Syndrome , 1992, Annals of the New York Academy of Sciences.

[48]  Venkatesan D. Vidi,et al.  Testosterone Supplementation in Heart Failure: A Meta-Analysis , 2012, Circulation. Heart failure.

[49]  M. Bunck,et al.  Fifty-two-week treatment with diet and exercise plus transdermal testosterone reverses the metabolic syndrome and improves glycemic control in men with newly diagnosed type 2 diabetes and subnormal plasma testosterone. , 2009, Journal of andrology.

[50]  P. Dandona,et al.  Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes. , 2004, The Journal of clinical endocrinology and metabolism.

[51]  E. Metter,et al.  Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. , 2001, The Journal of clinical endocrinology and metabolism.

[52]  D. Kivlahan,et al.  Low serum testosterone and mortality in male veterans. , 2006, Archives of internal medicine.

[53]  K. Williams,et al.  Atherosclerosis--an inflammatory disease. , 1999, The New England journal of medicine.

[54]  A. Araujo,et al.  Association of sex hormones and C‐reactive protein levels in men , 2010, Clinical endocrinology.

[55]  J. Kaufman,et al.  Differential contribution of testosterone and estradiol in the determination of cholesterol and lipoprotein profile in healthy middle-aged men. , 2003, Atherosclerosis.

[56]  N. Smith,et al.  Testosterone treatment and mortality in men with low testosterone levels. , 2012, The Journal of clinical endocrinology and metabolism.

[57]  G. Rosano,et al.  Low testosterone levels are associated with coronary artery disease in male patients with angina , 2007, International Journal of Impotence Research.

[58]  R. Cannon,et al.  Effect of combined 17 beta-estradiol and vitamin E on low-density lipoprotein oxidation in postmenopausal women. , 1995, The American journal of cardiology.

[59]  F. Iellamo,et al.  Effect of long-acting testosterone treatment on functional exercise capacity, skeletal muscle performance, insulin resistance, and baroreflex sensitivity in elderly patients with chronic heart failure a double-blind, placebo-controlled, randomized study. , 2009, Journal of the American College of Cardiology.

[60]  Yoav Ben-Shlomo,et al.  Cortisol, Testosterone, and Coronary Heart Disease: Prospective Evidence From the Caerphilly Study , 2005, Circulation.

[61]  E. Barrett-Connor,et al.  Low serum testosterone and mortality in older men. , 2008, The Journal of clinical endocrinology and metabolism.

[62]  J. Meunier,et al.  Pituitary-testicular axis in diabetic men with and without sexual impotence. , 1978, Diabete & metabolisme.

[63]  G. Grunwald,et al.  Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels. , 2013, JAMA.

[64]  L. Kuller,et al.  Usefulness of sex steroid hormone levels in predicting coronary artery disease in men. , 1987, The American journal of cardiology.

[65]  R. Steeds,et al.  Men with coronary artery disease have lower levels of androgens than men with normal coronary angiograms. , 2000, European heart journal.

[66]  M. A. Lesser.  Testosterone propionate therapy in one hundred cases of angina pectoris. , 1946, The Journal of clinical endocrinology and metabolism.

[67]  P. Delmas,et al.  Serum concentrations of 17β‐E2 and 25‐hydroxycholecalciferol (25OHD) in relation to all‐cause mortality in older men – the MINOS study , 2009, Clinical endocrinology.

[68]  K. Channer,et al.  The effect of testosterone replacement therapy on adipocytokines and C-reactive protein in hypogonadal men with type 2 diabetes. , 2007, European journal of endocrinology.

[69]  I. Njølstad,et al.  Endogenous testosterone and the prospective association with carotid atherosclerosis in men: the Tromsø study , 2009, European Journal of Epidemiology.

[70]  M. Muñoz,et al.  Insulin-dependent diabetes affects testicular function by FSH- and LH-linked mechanisms. , 2004, Journal of andrology.

[71]  L. Fu,et al.  Relationship between testosterone and indexes indicating endothelial function in male coronary heart disease patients. , 2008, Asian journal of andrology.

[72]  P. Arini,et al.  Sex differences on the electrocardiographic pattern of cardiac repolarization: possible role of testosterone. , 2000, American heart journal.

[73]  W. Zareba,et al.  The relationship between sex hormones and lipid profile in men with coronary artery disease. , 2005, International journal of cardiology.

[74]  V. Marks,et al.  Differences in pituitary and testicular function between diabetic patients on insulin and oral anti-diabetic agents , 1978, Diabetologia.

[75]  A. Lenzi,et al.  Effects of Testosterone Undecanoate on Cardiovascular Risk Factors and Atherosclerosis in Middle-Aged Men with Late-Onset Hypogonadism and Metabolic Syndrome : Results from a 24-month , Randomized , Double-Blind , Placebo-Controlled Studyjsm , 2010 .

[76]  R. Prineas,et al.  Sex differences in the evolution of the electrocardiographic QT interval with age. , 1992, The Canadian journal of cardiology.

[77]  A. Hofman,et al.  Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: the Rotterdam study. , 2002, The Journal of clinical endocrinology and metabolism.

[78]  P. Ponikowski,et al.  Reduction in circulating testosterone relates to exercise capacity in men with chronic heart failure. , 2009, Journal of cardiac failure.

[79]  Amy T. Wang,et al.  Clinical review 1: Adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis. , 2010, The Journal of clinical endocrinology and metabolism.

[80]  E. Sarchielli,et al.  Testosterone partially ameliorates metabolic profile and erectile responsiveness to PDE5 inhibitors in an animal model of male metabolic syndrome. , 2009, The journal of sexual medicine.

[81]  J. H. Lee,et al.  Effect of oral administration of testosterone on brachial arterial vasoreactivity in men with coronary artery disease. , 2002, The American journal of cardiology.

[82]  R. Demirbağ,et al.  The Inverse Relationship Between Thoracic Aortic Intima Media Thickness and Testosterone Level , 2005, Endocrine research.

[83]  A J Moss,et al.  Electrocardiographic quantitation of ventricular repolarization. , 1989, Circulation.

[84]  S. Arver,et al.  Testosterone Replacement in Hypogonadal Men With Type 2 Diabetes and/or Metabolic Syndrome (the TIMES2 Study) , 2011, Diabetes Care.

[85]  F. Cavagnini,et al.  High Prevalence of Prolonged QT Interval in Obese Hypogonadal Males , 2011, Obesity.

[86]  K. Pirke,et al.  Age related changes in free plasma testosterone, dihydrotestosterone and oestradiol. , 1975, Acta endocrinologica.

[87]  I. Njølstad,et al.  Low testosterone and sex hormone-binding globulin levels and high estradiol levels are independent predictors of type 2 diabetes in men. , 2010, European journal of endocrinology.

[88]  H. Völzke,et al.  Prospective inverse associations of sex hormone concentrations in men with biomarkers of inflammation and oxidative stress. , 2012, Journal of andrology.

[89]  张曼娜.  Adverse effects of testosterone therapy in adult men:A systematic review and meta-analysis , 2010 .

[90]  S. A. Levine,et al.  The Therapeutic Value of Testosterone Propionate in Angina Pectoris , 1943 .

[91]  M. Bond,et al.  Association of coronary disease with segment-specific intimal-medial thickening of the extracranial carotid artery. , 1995, Circulation.

[92]  I. Unsal,et al.  Relationship between Endogenous Sex Hormone Levels, Lipoproteins and Coronary Atherosclerosis in Men Undergoing Coronary Angiography , 2000, Cardiology.

[93]  N. Keating,et al.  Diabetes and cardiovascular disease during androgen deprivation therapy: observational study of veterans with prostate cancer. , 2010, Journal of the National Cancer Institute.

[94]  P. Poole‐Wilson,et al.  Testosterone relaxes rabbit coronary arteries and aorta. , 1995, Circulation.

[95]  M. Vitiello,et al.  Loss of circadian rhythmicity in blood testosterone levels with aging in normal men. , 1983, The Journal of clinical endocrinology and metabolism.

[96]  G. Mehlhorn,et al.  Cardiomyoplasty - improvement of muscle fibre type transformation by an anabolic steroid (metenolone). , 1997, Journal of molecular and cellular cardiology.

[97]  A. Dobs,et al.  Male hypogonadism in systemic disease. , 2007, Endocrinology and metabolism clinics of North America.

[98]  E. Giltay,et al.  Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double‐blinded placebo‐controlled Moscow study , 2010, Clinical endocrinology.

[99]  Shuiping Zhao,et al.  The association of low plasma testosterone level with coronary artery disease in Chinese men. , 1998, International journal of cardiology.

[100]  M. Romano.  [Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina. A randomized, double-blind, placebo-controlled study]. , 2001, Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology.

[101]  S. Yeh,et al.  Insulin and leptin resistance with hyperleptinemia in mice lacking androgen receptor. , 2005, Diabetes.

[102]  M. Lehmann,et al.  Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. , 1993, JAMA.

[103]  J. Nettleship,et al.  Testosterone and coronary artery disease. , 2009, Frontiers of hormone research.

[104]  O. Raitakari,et al.  Increased carotid atherosclerosis in andropausal middle-aged men. , 2005, Journal of the American College of Cardiology.

[105]  J. Mckinlay,et al.  Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study. , 1991, The Journal of clinical endocrinology and metabolism.

[106]  E. Ding,et al.  Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. , 2006, JAMA.

[107]  K. Channer,et al.  Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. , 2006, European journal of endocrinology.

[108]  E. Guallar,et al.  Sex steroid hormone concentrations and risk of death in US men. , 2010, American journal of epidemiology.

[109]  Martin L. Lee,et al.  Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials. , 2005, The journals of gerontology. Series A, Biological sciences and medical sciences.

[110]  A. Moss,et al.  Age-gender influence on the rate-corrected QT interval and the QT-heart rate relation in families with genotypically characterized long QT syndrome. , 1997, Journal of the American College of Cardiology.

[111]  S. Gapstur,et al.  The association of endogenous sex hormones with lipoprotein subfraction profile in the Multi-Ethnic Study of Atherosclerosis. , 2008, Metabolism: clinical and experimental.

[112]  C. Hayward,et al.  Testosterone enhances flow-mediated brachial artery reactivity in men with coronary artery disease. , 2000, The American journal of cardiology.

[113]  D. Grobbee,et al.  Grobbee Endogenous Sex Hormones and Cardiovascular Disease in Men Society , 2003 .

[114]  K. Channer,et al.  The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men. , 2004, The Journal of clinical endocrinology and metabolism.

[115]  S. Bandinelli,et al.  Correlation between testosterone and the inflammatory marker soluble interleukin-6 receptor in older men. , 2006, The Journal of clinical endocrinology and metabolism.

[116]  Z. Mo,et al.  Endogenous sex hormones and C‐reactive protein in healthy chinese men , 2013, Clinical endocrinology.

[117]  A. Araujo,et al.  Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. , 2002, The Journal of clinical endocrinology and metabolism.

[118]  Y. Ouchi,et al.  Low testosterone level as a predictor of cardiovascular events in Japanese men with coronary risk factors. , 2010, Atherosclerosis.

[119]  W. März,et al.  Low free testosterone is associated with heart failure mortality in older men referred for coronary angiography , 2011, European journal of heart failure.

[120]  A. Lenzi,et al.  Type 2 diabetes mellitus and testosterone: a meta-analysis study. , 2011, International journal of andrology.

[121]  G. Forti,et al.  Following the common association between testosterone deficiency and diabetes mellitus, can testosterone be regarded as a new therapy for diabetes? , 2009, International journal of andrology.

[122]  P Pignoli,et al.  Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. , 1986, Circulation.

[123]  J. Ivey,et al.  Differential effects of androgens on coronary blood flow regulation and arteriolar diameter in intact and castrated swine , 2012, Biology of Sex Differences.

[124]  I. Godsland,et al.  Sex, plasma lipoproteins, and atherosclerosis: prevailing assumptions and outstanding questions. , 1987, American heart journal.

[125]  The effects of varying doses of T on insulin sensitivity, plasma lipids, apolipoproteins, and C-reactive protein in healthy young men. , 2002, The Journal of clinical endocrinology and metabolism.

[126]  Jacques Young,et al.  Effects of testosterone on ventricular repolarization in hypogonadic men. , 2009, The American journal of cardiology.

[127]  P. Ponikowski,et al.  Anabolic Deficiency in Men With Chronic Heart Failure: Prevalence and Detrimental Impact on Survival , 2006, Circulation.

[128]  A. Vermeulen,et al.  A critical evaluation of simple methods for the estimation of free testosterone in serum. , 1999, The Journal of clinical endocrinology and metabolism.

[129]  S. Anker,et al.  Tumor necrosis factor and steroid metabolism in chronic heart failure: possible relation to muscle wasting. , 1997, Journal of the American College of Cardiology.

[130]  D. Grobbee,et al.  Endogenous Sex Hormones and Progression of Carotid Atherosclerosis in Elderly Men , 2004, Circulation.

[131]  K. Chatterjee,et al.  Testosterone induces dilation of canine coronary conductance and resistance arteries in vivo. , 1996, Circulation.

[132]  D. Siscovick,et al.  Intramuscular testosterone esters and plasma lipids in hypogonadal men: a meta-analysis. , 2001, The American journal of medicine.

[133]  P. Schwartz,et al.  Are gender differences in QTc present at birth? MISNES Investigators. Multicenter Italian Study on Neonatal Electrocardiography and Sudden Infant Death Syndrome. , 1995, The American journal of cardiology.

[134]  P. Ponikowski,et al.  Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. , 1997, Circulation.

[135]  E. Barrett-Connor,et al.  High serum testosterone is associated with reduced risk of cardiovascular events in elderly men. The MrOS (Osteoporotic Fractures in Men) study in Sweden. , 2011, Journal of the American College of Cardiology.

[136]  F. Iellamo,et al.  Testosterone therapy in women with chronic heart failure: a pilot double-blind, randomized, placebo-controlled study. , 2010, Journal of the American College of Cardiology.

[137]  M. Bots,et al.  Endogenous hormones and carotid atherosclerosis in elderly men. , 2003, American journal of epidemiology.

[138]  V. Montori,et al.  Testosterone and cardiovascular risk in men: a systematic review and meta-analysis of randomized placebo-controlled trials. , 2007, Mayo Clinic proceedings.

[139]  V. Papadopoulos,et al.  Aging and Luteinizing Hormone Effects on Reactive Oxygen Species Production and DNA Damage in Rat Leydig Cells1 , 2013, Biology of reproduction.

[140]  R. Klein,et al.  Role of brain insulin receptor in control of body weight and reproduction. , 2006, Science.

[141]  A. Moss,et al.  The Long QT Syndrome: Prospective Longitudinal Study of 328 Families , 1991, Circulation.

[142]  W. Frishman,et al.  Testosterone and Coronary Artery Disease , 2010, Cardiology in review.

[143]  F. Pecori Giraldi,et al.  High Prevalence of Prolonged QT Interval Duration in Male Patients with Cushing's Disease , 2011, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[144]  J. Dunn,et al.  Transport of steroid hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma. , 1981, The Journal of clinical endocrinology and metabolism.

[145]  E. V. van Beek,et al.  Testosterone therapy in men with moderate severity heart failure: a double-blind randomized placebo controlled trial. , 2006, European heart journal.

[146]  A. Matsumoto,et al.  The effects of aging in normal men on bioavailable testosterone and luteinizing hormone secretion: response to clomiphene citrate. , 1987, The Journal of clinical endocrinology and metabolism.

[147]  M. Lehmann,et al.  Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs , 1993 .

[148]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2012 update: a report from the American Heart Association. , 2012, Circulation.

[149]  F. Pecori Giraldi,et al.  Increased prevalence of prolonged QT interval in males with primary or secondary hypogonadism: a pilot study. , 2010, International journal of andrology.

[150]  E. Barrett-Connor,et al.  Sex hormones and age: a cross-sectional study of testosterone and estradiol and their bioavailable fractions in community-dwelling men. , 1998, American journal of epidemiology.

[151]  R. Ross,et al.  Atherosclerosis is an inflammatory disease. , 1998, American heart journal.

[152]  A. Jette,et al.  Adverse events associated with testosterone administration. , 2010, The New England journal of medicine.

[153]  N. LeBrasseur,et al.  Effects of dihydrotestosterone on differentiation and proliferation of human mesenchymal stem cells and preadipocytes , 2008, Molecular and Cellular Endocrinology.

[154]  J. Morley,et al.  The benefits and risks of testosterone replacement therapy: a review , 2009, Therapeutics and clinical risk management.

[155]  R. Jones,et al.  Testosterone treatment for men with chronic heart failure , 2004, Heart.

[156]  C. Webb,et al.  Effect of acute testosterone on myocardial ischemia in men with coronary artery disease. , 1999, The American journal of cardiology.

[157]  R. Baggott.  DISEASE , 1947, Social Policy & Administration.

[158]  T. Yoshikawa,et al.  Association between serum testosterone concentration and carotid atherosclerosis in men with type 2 diabetes. , 2003, Diabetes care.

[159]  P. Morris,et al.  Low serum testosterone and increased mortality in men with coronary heart disease , 2010, Heart.

[160]  H. Teede,et al.  Evidence that parenteral testosterone therapy may improve endothelium-dependent and -independent vasodilation in postmenopausal women already receiving estrogen. , 2001, The Journal of clinical endocrinology and metabolism.

[161]  L. Niskanen,et al.  Sex hormones, inflammation and the metabolic syndrome: a population-based study. , 2003, European journal of endocrinology.